Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05675202
What this trial is testing

Material Balance Study of TQ-B3525

Who this might be right for
Chronic Kidney DiseasesMagnetic Resonance Imaging
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 8
Early research (Phase 1)Study completedNCT07070375
What this trial is testing

Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Gram-negative Bacterial Infections
Jiangsu HengRui Medicine Co., Ltd. 33
Early research (Phase 1)Study completedNCT06643377
What this trial is testing

A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032)

Who this might be right for
HealthyRenal Impairment
Merck Sharp & Dohme LLC 27
Early research (Phase 1)UnknownNCT06344936
What this trial is testing

Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects

Who this might be right for
Chronic Kidney Disease(CKD)
Shandong Suncadia Medicine Co., Ltd. 28
Early research (Phase 1)Looking for participantsNCT07021157
What this trial is testing

Evaluate the Safety, Tolerability and PK of SK-08

Who this might be right for
Chronic Kidney Disease(CKD)
Consun Pharmaceutical Group 48
Not applicableStudy completedNCT04222153
What this trial is testing

Innovative Approach to Fecal Microbiota Transplantation (FMT) Applied for Chronic Kidney Disease (CKD)

Who this might be right for
HealthyChronic Kidney Diseases
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 10
Testing effectiveness (Phase 2)Looking for participantsNCT06749457
What this trial is testing

Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Who this might be right for
Staphylococcus Aureus
AstraZeneca 231
Early research (Phase 1)Study completedNCT06715670
What this trial is testing

Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian and Japanese Participants

Who this might be right for
Liver Cirrhosis
AstraZeneca 30
Early research (Phase 1)Study completedNCT07032272
What this trial is testing

Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

Who this might be right for
Autoimmune and Chronic Inflammatory Diseases
Novartis Pharmaceuticals 16
Not applicableStudy completedNCT00696605
What this trial is testing

Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion

Who this might be right for
HypoosmolalityHyperosmolalityRenal Failure
Hospital Centre Biel/Bienne 20
Early research (Phase 1)Study completedNCT01737866
What this trial is testing

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

Who this might be right for
Heart Failure
Cytokinetics 13
Early research (Phase 1)Study completedNCT01761773
What this trial is testing

A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

Who this might be right for
HealthyRenal Impairment
Exelixis 32
Early research (Phase 1)Study completedNCT01006057
What this trial is testing

A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 32
Not applicableUnknownNCT05225454
What this trial is testing

The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques

Who this might be right for
Chronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2Chronic Kidney Disease Stage 3+4 more
Far Eastern Memorial Hospital 81,108
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT02852239
What this trial is testing

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 22
Early research (Phase 1)Study completedNCT05936138
What this trial is testing

A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.

Who this might be right for
Renal InsufficiencyHealthy
Eli Lilly and Company 24
Post-approval studies (Phase 4)Study completedNCT01132157
What this trial is testing

Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal Transplantation

Who this might be right for
HealthyEnd Stage Renal Disease
Yonsei University 99
Early research (Phase 1)Study completedNCT07165015
What this trial is testing

Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

Who this might be right for
Renal ImpairmentHealthyRenal Insufficiency+1 more
Eli Lilly and Company 31
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Next Page